Sands Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,284,744
Closed -$324M 81
2020
Q3
$324M Buy
2,284,744
+47,293
+2% +$7.88M 0.7% 41
2020
Q2
$441M Buy
2,237,451
+7,198
+0.3% +$1.49M 1.07% 31
2020
Q1
$437M Sell
2,230,253
-413,555
-16% -$89M 1.46% 24
2019
Q4
$547M Sell
2,643,808
-110,752
-4% -$20.5M 1.59% 25
2019
Q3
$421M Sell
2,754,560
-58,749
-2% -$9.63M 1.35% 25
2019
Q2
$363M Sell
2,813,309
-68,951
-2% -$8.18M 1.08% 27
2019
Q1
$339M Sell
2,882,260
-12,275
-0.4% -$1.24M 1.05% 31
2018
Q4
$266M Sell
2,894,535
-104,804
-3% -$10.6M 0.95% 34
2018
Q3
$337M Buy
2,999,339
+1,155,853
+63% +$122M 0.95% 30
2018
Q2
$170M Sell
1,843,486
-35,200
-2% -$3.42M 0.49% 36
2018
Q1
$187M Sell
1,878,686
-119,625
-6% -$12.9M 0.55% 34
2017
Q4
$187M Sell
1,998,311
-37,705
-2% -$3.57M 0.57% 35
2017
Q3
$207M Sell
2,036,016
-102,475
-5% -$8.95M 0.62% 35
2017
Q2
$164M Buy
+2,138,491
New +$180M 0.49% 39

Other funds holding LKFT

Sands Capital Management's LKFT Position: Q4 2020 in Review

Sands Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 2,284,744 shares — an estimated $324M sold.

Sands Capital Management first reported a position in LKFT in Q2 2017 and held it in 14 quarters. The position peaked at $547M in Q4 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • Sands Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Sands Capital Management sold 2,284,744 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $324M.
  • Sands Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 14 quarters.
  • Sands Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $547M in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Sands Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.